Finance entity
markets is the sole category represented across all 1 tracked stories. Jupiter Neurosciences is most often covered alongside GlobeNewsWire, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.1 for the broader beat in this window.
Last mentioned: 1h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
markets is the sole category represented across all 1 tracked stories. Jupiter Neurosciences is most often covered alongside GlobeNewsWire, which appears in 1 of these 1 story. Each story carries 2 original sources on average, compared with 2.1 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.5 for that window. Jupiter Neurosciences appears in 1 tracked Finance story from August 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Jupiter Neurosciences. Shared-story counts are live from our verified record — not editorial picks.
Jupiter Neurosciences announced a $2.0 million registered direct offering on August 21, 2026, a micro-cap deal structure that typically clears at a discount and introduces immediate equity supply. For finance professionals, the focus is on deal terms, dilution, and post-announcement JUP trading patterns.
Jupiter Neurosciences is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
